Rare diseases
Investigational molecules
Locations
Study of Tebentafusp and Pembrolizumab for Patients with Previously Treated Advanced Melanoma
PolandStudy on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer
PolandStudy on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia
PolandStudy on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17
PolandStudy for Patients with Various Tumor Types Continuing Osimertinib Treatment After Previous Oncology Study Completion
PolandStudy on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer
PolandLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
PolandStudy Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma
PolandStudy on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis
PolandStudy on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine
PolandStudy on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma
PolandStudy of Taletrectinib for Patients with Advanced or Metastatic ROS1 Positive Non-Small Cell Lung Cancer
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
